Remdesivir

FDA Extends EUA for Remdesivir in Covid Patients

The US Food and Drug Administration (FDA) has come under fire again as the federal health agency issued its third Emergency Use Authorization (EUA) for a Covid-19 treatment since the beginning of the pandemic. This extended the authorization for Gilead’s remdesivir, which it markets as Veklury.

EU Inks Remdesivir Supply Deal with Gilead

The European Commission has signed a €63 million contract with Gilead Sciences to deliver batches of Veklury, Gilead’s name for the antiviral remdesivir, to the EU’s 27 member states as well as the UK, starting in early August.

US Nabs Bulk of World Remdesivir Supply

As the global coronavirus pandemic shows no signs of abating, the US “America first” approach to preventing and treating Covid-19 has again provoked worldwide concern.

Dr. Reddy's Enters into a Licensing Agreement with Gilead for Remdesivir